| Nov 18 |
Cassava taps Freda Nassif as chief commercial officer as simufilam Phase 3 readout nears
|
| Nov 18 |
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
|
| Nov 15 |
Cassava Sciences updates on Phase 3 Alzheimer’s trial ahead of key readout
|
| Nov 15 |
Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?
|
| Nov 12 |
What Makes Cassava Sciences (SAVA) a New Buy Stock
|
| Nov 11 |
Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
|
| Nov 8 |
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
|
| Nov 8 |
Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting
|
| Nov 7 |
Cassava Sciences: Pivotal Alzheimer's Data May Push Stock Toward Book Value
|
| Nov 7 |
Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh
|
